2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow BDB001 (EIK1001): new trials by email Literature Review of BDB001 (EIK1001) trials Research Report on BDB001 (EIK1001)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| BDB001-102: Open Label Dose Escalation of BDB001 in Combination w Atezolizumab BDB001 (EIK1001), Atezolizumab - Tumor, Solid | Phase 1 | Completed | Eikon Therapeutics | 40 | 2019-11-21 | 2025-11-12 |
| BDB001-101: Clinical Study of BDB001 as a Mono-therapy or in Combination With Pembrolizumab BDB001 (EIK1001), Pembrolizumab - Tumor, Solid | Phase 1 | Completed | Eikon Therapeutics | 87 | 2018-02-15 | 2025-11-12 |
Neoplasms (2)
United States (2)